Deals

Sino Biopharmaceutical's CTTQ Partners With STADA on Pembrolizumab Biosimilar TQB3570 – Exclusive European License With Options Across Oncology and Immunology
BiosimilarsHKG: 1177

Sino Biopharmaceutical’s CTTQ Partners With STADA on Pembrolizumab Biosimilar TQB3570 – Exclusive European License With Options Across Oncology and Immunology

Sino Biopharmaceutical (HKG: 1177) announced that its subsidiary Jiangsu Chia Tai Tianqing Pharmaceutical Co., Ltd. (CTTQ) has entered into a strategic biosimilar collaboration with European pharmaceutical company STADA Arzneimittel AG…

Sinovac and Egypt's GENNVAX Launch sIPV Technical Cooperation Project in Beijing – Sabin Inactivated Polio Vaccine Localization Deal Enters Implementation Phase

Sinovac and Egypt’s GENNVAX Launch sIPV Technical Cooperation Project in Beijing – Sabin Inactivated Polio Vaccine Localization Deal Enters Implementation Phase

Merck Licenses SciBrunch's Oral KRAS G12D Inhibitor SPR2015 in Up to USD 2.13 Billion Exclusive Global Deal

Merck Licenses SciBrunch’s Oral KRAS G12D Inhibitor SPR2015 in Up to USD 2.13 Billion Exclusive Global Deal

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Baheal Pharmaceutical Gains Exclusive Rights to Roche's MabThera in China
Baheal PharmaceuticalCancer

Baheal Pharmaceutical Gains Exclusive Rights to Roche’s MabThera in China

CStone Pharmaceuticals and SteinCares Ink Licensing Deal for PD-L1 Inhibitor in Latin America
CancerCStone Pharmaceuticals

CStone Pharmaceuticals and SteinCares Ink Licensing Deal for PD-L1 Inhibitor in Latin America

Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206
Auto-immuneBio-Thera Solutions

Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206

Hainan Poly Pharm's US Partner Slate Run Pharmaceuticals Collaborates with Premier on Contrast Agents
NASDAQ: PINCPoly Pharm

Hainan Poly Pharm’s US Partner Slate Run Pharmaceuticals Collaborates with Premier on Contrast Agents

Show More